Literature DB >> 17996728

In vitro selection of optimal RelB/p52 DNA-binding motifs.

Liudmila V Britanova1, Vsevolod J Makeev, Dmitry V Kuprash.   

Abstract

Rel/NF-kB dimers of different subunit composition can activate distinct subsets of target genes in vivo, however, the role of DNA recognition in this specificity is not well understood. We set out to study the DNA-binding ability of RelB/p52, the least studied of all NF-kB proteins and the main transcriptionally active product of the alternative NF-kB signaling pathway. We searched for optimal binding sites for RelB/p52 by random site selection method, using full-length proteins expressed in eukaryotic cells. The subset of RelB/p52-binding sequences defines a consensus which is very similar to the classical RelA/p50 consensus. Importantly, each of these binding sites is also recognized by RelA/p50 heterodimer with comparable affinity, questioning the existence of RelB/p52-specific kappa B sites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996728     DOI: 10.1016/j.bbrc.2007.10.200

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes.

Authors:  Amanda J Fusco; De-Bin Huang; Dustyn Miller; Vivien Ya-Fan Wang; Don Vu; Gourisankar Ghosh
Journal:  EMBO Rep       Date:  2008-12-19       Impact factor: 8.807

Review 2.  The NF-kappaB family of transcription factors and its regulation.

Authors:  Andrea Oeckinghaus; Sankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

3.  Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.

Authors:  Sarah Jill de Jong; Jens-Christian Albrecht; Monika Schmidt; Ingrid Müller-Fleckenstein; Brigitte Biesinger
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

Review 4.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 5.  Genome reading by the NF-κB transcription factors.

Authors:  Maria Carmen Mulero; Vivien Ya-Fan Wang; Tom Huxford; Gourisankar Ghosh
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

Review 6.  Non-canonical NF-κB signaling pathway.

Authors:  Shao-Cong Sun
Journal:  Cell Res       Date:  2010-12-21       Impact factor: 25.617

7.  BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.

Authors:  Lars Pache; Miriam S Dutra; Adam M Spivak; John M Marlett; Jeffrey P Murry; Young Hwang; Ana M Maestre; Lara Manganaro; Mitchell Vamos; Peter Teriete; Laura J Martins; Renate König; Viviana Simon; Alberto Bosque; Ana Fernandez-Sesma; Nicholas D P Cosford; Frederic D Bushman; John A T Young; Vicente Planelles; Sumit K Chanda
Journal:  Cell Host Microbe       Date:  2015-09-09       Impact factor: 21.023

Review 8.  A single NFκB system for both canonical and non-canonical signaling.

Authors:  Vincent Feng-Sheng Shih; Rachel Tsui; Andrew Caldwell; Alexander Hoffmann
Journal:  Cell Res       Date:  2010-11-23       Impact factor: 25.617

9.  Classical and alternative NF-κB signaling cooperate in regulating adipocyte differentiation and function.

Authors:  A Weidemann; A Lovas; A Rauch; N Andreas; J von Maltzahn; M Riemann; F Weih
Journal:  Int J Obes (Lond)       Date:  2015-09-25       Impact factor: 5.095

10.  Attenuation of inflammatory mediator production by the NF-κB member RelB is mediated by microRNA-146a in lung fibroblasts.

Authors:  David H McMillan; Collynn F Woeller; Thomas H Thatcher; Sherry L Spinelli; Sanjay B Maggirwar; Patricia J Sime; Richard P Phipps
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-05       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.